Corporate Governance

About

The Annual General Meeting is Active Biotech’s highest decision-making body. At the Annual General Meeting, which is held not more than six months after the close of the fiscal year, the annual accounts for the preceding year are approved, the Board of Directors is elected, auditors are elected when necessary and statutory matters are addressed. Between General Meetings, the Board of Directors is the company’s highest decision-making body.

In accordance with Active Biotech’s Articles of Association, the Board shall comprise between three and nine members with at most nine deputies.

General Meetings

Audit committee

Audit committee

The Audit committee consist of the following members; Peter Thelin and Michael Shalmi.

The purpose of the Audit committee is to increase the board of directors focus to the audit process and audit results of the company, and to facilitate an improved contact between the board of directors and the company´s auditor thereby improving the review of the company´s financial risk exposure, risk management and financial reporting.

The Audit committee shall report its decisions, proposals, findings, and conclusions to the board of directors.

  • Michael Shalmi

  • Peter Thelin

Scientific committee

Scientific committee

The Scientific committee consists of the following members; Axel Glasmacher (Chair) and Aleksandar Danilovski.

The purpose of the Scientific committee is to provide input and advise board and management of Active Biotech on matters relating to the company’s research and development strategy, including review of the company’s planned or ongoing research activities and plans. To accomplish this, the Scientific committee will, on its own and/or together with external experts, as deemed appropriate, on a regular basis evaluate, and monitor the scientific plans as well as individual project progress and performance of the company’s project portfolio. The Scientific committee is a resource to management, and members of the Scientific committee may be consulted individually or collectively. The meetings in the committee are prepared by the company’s Chief Scientific Officer together with the Chair of the committee.

The Scientific committee shall to the board of directors provide strategic advice on emerging regulatory, clinical and scientific issues pertaining to the project portfolio of Active Biotech or areas of special interest to the company.

  • Aleksandar Danilovski

  • Axel Glasmacher

Election Committee

In accordance with a decision made by the Annual General Meeting held on May 20, 2026, the Election Committee shall comprise the representatives for the three largest shareholders, as per end of September 2026, and the Chairman of the Board.

For the 2027 Annual General Meeting, the Election Committee shall propose Board members and a Chairman of the Board, and fees to Board members and auditors.

Under the leadership of the Chairman of the Board the Election Committee shall prepare proposals for the Board of Directors that are to be presented to and decided upon at the 2027 Annual General Meeting.

Shareholders wishing to submit proposals to the election committee may address these to magnus.svensson@activebiotech.com.

Auditors

Auditors

Cecilia Andrén Dorselius has been the auditor in charge since 2023.

  • Cecilia Andrén Dorselius

    Principle auditor

    Auditor in charge since 2023

    PricewaterhouseCoopers
    Authorized Public Accountant PwC.